Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmconsul s.r.o. - metforminhydrochlorid - filmovertrukne tabletter - 500 mg

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

astrazeneca ab - metformin hydrochlorid, dapagliflozin propandiol monohydrat - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - xigduo er indiceret hos voksne til behandling af type 2-diabetes som et supplement til kost og motion:• i patienter ikke er tilstrækkeligt kontrolleret på deres maksimalt tolereret dosis af metformin alene • i kombination med andre lægemidler til behandling af diabetes i patienter, der er utilstrækkeligt kontrolleret med metformin og disse lægemidler• hos patienter, der allerede behandles med en kombination af dapagliflozin og metformin som særskilte tabletter. for undersøgelsens resultater med hensyn til kombination af behandlinger, effekt på glykæmisk kontrol og hjerte-kar-hændelser, og de befolkninger, der studerede, se afsnit 4. 4, 4. 5 og 5.

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Eiropas Savienība - dāņu - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

laurus generics gmbh - metforminhydrochlorid - filmovertrukne tabletter - 500 mg

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

vitabalans oy - metforminhydrochlorid - filmovertrukne tabletter - 500 mg

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - metforminhydrochlorid - filmovertrukne tabletter - 1000 mg

Dānija - dāņu - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - metforminhydrochlorid - filmovertrukne tabletter - 850 mg